284 related articles for article (PubMed ID: 3023210)
1. Inhibition of platelet thromboxane generation by suloctidil in man.
Bucchi F; Cerletti C; de Gaetano G
Haemostasis; 1986; 16(5):362-8. PubMed ID: 3023210
[TBL] [Abstract][Full Text] [Related]
2. Fenflumizole: interactions with the arachidonic acid cascade.
Corell T; Hasselmann G; Splawinski J; Wojtaszek B
Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
[TBL] [Abstract][Full Text] [Related]
3. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
Parry MJ
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of arachidonic acid induced-aggregation of rabbit platelets with CV-4151 (isbogrel), a selective thromboxane A2 (TXA2) synthase inhibitor: modulation of the antiplatelet action and prostanoid metabolism by rat aortic rings.
Terashita Z; Imura Y; Nishikawa K
J Lipid Mediat Cell Signal; 1996 Jan; 13(1):1-8. PubMed ID: 8821806
[TBL] [Abstract][Full Text] [Related]
5. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
[TBL] [Abstract][Full Text] [Related]
6. Altered renal and platelet arachidonic acid metabolism in cirrhosis.
Laffi G; La Villa G; Pinzani M; Ciabattoni G; Patrignani P; Mannelli M; Cominelli F; Gentilini P
Gastroenterology; 1986 Feb; 90(2):274-82. PubMed ID: 3079716
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of platelet aggregation and thromboxane production by pinacidil.
Goodman RP; Little DM; Wright JT
Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Reilly IA; FitzGerald GA
Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
[TBL] [Abstract][Full Text] [Related]
9. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
10. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
12. Selective and nonselective inhibition of thromboxane formation.
FitzGerald GA; Oates JA
Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
[TBL] [Abstract][Full Text] [Related]
13. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Rosenkranz B; Fischer C; Meese CO; Frölich JC
Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Toivanen J; Ylikorkala O; Viinikka L
Thromb Res; 1985 Feb; 37(4):493-502. PubMed ID: 3920778
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human platelet function in vitro and ex vivo by acetaminophen.
Lages B; Weiss HJ
Thromb Res; 1989 Mar; 53(6):603-13. PubMed ID: 2499947
[TBL] [Abstract][Full Text] [Related]
17. Effects of SQ 27,427, a thromboxane A2 receptor antagonist, in the human platelet and isolated smooth muscle.
Harris DN; Greenberg R; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Steinbacher TE
Eur J Pharmacol; 1984 Aug; 103(1-2):9-18. PubMed ID: 6090180
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
Kyrle PA; Eichler HG; Jäger U; Lechner K
Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
[TBL] [Abstract][Full Text] [Related]
19. Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.
Faili A; Randon J; Vargaftig BB; Hatmi M
Biochem Pharmacol; 1993 May; 45(9):1815-20. PubMed ID: 8388209
[TBL] [Abstract][Full Text] [Related]
20. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
